| - Industry | - Sector | Kohei Toda CEO | JPX Exchange | - ISIN |
| Japan Country | - Employees | - Last Dividend | - Last Split | - IPO Date |
Cliniphar Co., Ltd. is a prominent holding company established in 2017, specializing in the wholesale and distribution of pharmaceuticals in both the domestic Japanese market and international arenas. With its headquarters located in Osaka, Cliniphar is instrumental in enhancing healthcare logistics by effectively integrating its subsidiaries and harnessing synergies within the healthcare industry. The company is dedicated to delivering efficiency and innovation in pharmaceutical distribution, showcasing its significant role in advancing supply chain processes.
Cliniphar manages an expansive portfolio of over 17,000 prescription products, collaborating closely with approximately 12,000 healthcare professionals and institutions. Its strong market presence emphasizes its critical function as an intermediary in the healthcare ecosystem, facilitating supply chain innovation and reliability to ensure hospitals, clinics, and pharmacies have reliable access to a comprehensive range of pharmaceuticals.
Cliniphar specializes in the wholesale distribution of a wide array of pharmaceutical products, serving as a vital link between manufacturers and healthcare providers. By managing an extensive portfolio, the company ensures that healthcare institutions have access to essential medications and treatments.
Cliniphar operates advanced B2B e-commerce platforms tailored for healthcare providers, including Kosei Market. These platforms enhance the accessibility and ordering process of pharmaceutical products, streamlining communications between distributors and healthcare professionals.
Through resources like Synapse, Cliniphar maintains comprehensive digital drug databases that serve both the Japanese and global medical sectors. These databases assist healthcare providers in obtaining crucial information regarding pharmaceutical products, dosage guidelines, and availability.
Cliniphar is committed to innovating healthcare logistics. By integrating its subsidiaries and optimizing supply chain processes, the company plays a pivotal role in ensuring a stable supply of pharmaceutical products to various healthcare facilities.